Sign In
Buy AMED
$100.99
+0 (+0%)
At Close: Nov 13, 2025
Amedisys, Inc. (AMED) CEO Christopher Gerard on Q1 2022 Results - Earnings Call Transcript
05:45pm, Thursday, 28'th Apr 2022
Amedisys, Inc. (NASDAQ:AMED ) Q1 2022 Earnings Conference Call April 28, 2022 11:00 AM ET Company Participants Nick Muscato - Chief Strategy Officer Christopher Gerard - CEO, President & Director Scot
Amedisys (AMED) Q1 Earnings Surpass Estimates, Margins Down
02:31pm, Thursday, 28'th Apr 2022 Zacks Investment Research
Impressive performance by the Home Health and Hospice segments drove Amedisys' (AMED) revenues in the first quarter.
Amedisys (AMED) Q1 Earnings Surpass Estimates, Margins Down
12:04pm, Thursday, 28'th Apr 2022
Impressive performance by the Home Health and Hospice segments drove Amedisys' (AMED) revenues in the first quarter.
Amedisys (AMED) Q1 Earnings Top Estimates
09:45pm, Wednesday, 27'th Apr 2022 Zacks Investment Research
Amedisys (AMED) delivered earnings and revenue surprises of 10.81% and 2.25%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?
Amedisys Reports First Quarter 2022 Financial Results and Reaffirms 2022 Guidance
08:05pm, Wednesday, 27'th Apr 2022 GlobeNewswire Inc.
BATON ROUGE, La., April 27, 2022 (GLOBE NEWSWIRE) -- Amedisys, Inc. (NASDAQ: AMED) today reported its financial results for the three-month period ended March 31, 2022.
Amedisys Announces First Quarter 2022 Earnings Release and Conference Call Date
12:00pm, Wednesday, 13'th Apr 2022 GlobeNewswire Inc.
BATON ROUGE, La., April 13, 2022 (GLOBE NEWSWIRE) -- Amedisys, Inc. (NASDAQ: AMED), a leading provider of quality home health, hospice, personal care and high-acuity care, will report results for th
Amedisys Announces First Quarter 2022 Earnings Release and Conference Call Date
08:00am, Wednesday, 13'th Apr 2022
BATON ROUGE, La., April 13, 2022 (GLOBE NEWSWIRE) -- Amedisys, Inc. (NASDAQ: AMED), a leading provider of quality home health, hospice, personal care and high-acuity care, will report results for the
Here's Why You Should Retain Amedisys (AMED) Stock For Now
02:11pm, Thursday, 07'th Apr 2022 Zacks Investment Research
Investors are optimistic about Amedisys' (AMED) strong segmental performance and strategic buyouts.
Amedisys Completes Acquisition of Evolution Health
12:00pm, Monday, 04'th Apr 2022 GlobeNewswire Inc.
BATON ROUGE, La., April 04, 2022 (GLOBE NEWSWIRE) -- Amedisys, Inc. (NASDAQ: AMED), a leading provider of quality home health, hospice, personal care and high-acuity care, has closed on its acquisit
Amedisys Completes Acquisition of Home Health Assets from AssistedCare Home Health and AssistedCare of the Carolinas
12:00pm, Monday, 04'th Apr 2022 GlobeNewswire Inc.
BATON ROUGE, La., April 04, 2022 (GLOBE NEWSWIRE) -- Amedisys, Inc. (NASDAQ: AMED), a leading provider of quality home health, hospice, personal care and high-acuity care, has closed on its acquisit
Why Is Amedisys (AMED) Up 13.2% Since Last Earnings Report?
03:30pm, Friday, 25'th Mar 2022 Zacks Investment Research
Amedisys (AMED) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Why Is Amedisys (AMED) Up 13.2% Since Last Earnings Report?
01:32pm, Friday, 25'th Mar 2022
Amedisys (AMED) reported earnings 30 days ago. What's next for the stock?
Ukraine Has Received $100M In Crypto Donations: Here''s Where The Funds Are Going
10:11am, Monday, 14'th Mar 2022 Benzinga
Ukraine has received nearly $100 million worth of cryptocurrency donations, according to a report from CoinDesk . What Happened: Alex Bornyakov, Ukraine’s Deputy Minister for Digital Transformation, revealed that over $60 million of the funds had been sent to the main fund run by Ukrainian cryptocurrency exchange Kuna. The rest of the funds have been sent to several smaller funds, Bornyakov said in an emergency online briefing entitled "Digital Resistance: How Ukraine Is Leveraging Technology to Fight for Freedom.” Crypto assets proved extremely helpful in facilitation of funding flows to the Amed Forces of … Full story available on Benzinga.com
New Strong Sell Stocks for March 9th
12:45pm, Wednesday, 09'th Mar 2022 Zacks Investment Research
AGESY, AMED, and APAM have been added to the Zacks Rank #5 (Strong Sell) List on March 9, 2022.
New Strong Sell Stocks for March 9th
09:02am, Wednesday, 09'th Mar 2022
AGESY, AMED, and APAM have been added to the Zacks Rank #5 (Strong Sell) List on March 9, 2022.
